| Market Cap | 8.9B |
| Market Cap (USD) | $1.2B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 0.46 |
| Dividend Yield | - |
| D/E Ratio | 0.70 |
| Current Ratio | 2.02 |
| Market Segment | Main Board |
| Currency | CNY |
Business Overview
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections and others. The company's brands such as Luotai, Tianxuanqing, Artemedine, Artem and Arco. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | C27医药制造业 |
| Market Segment | Main Board |
| Currency | CNY |
| Fiscal Year | 2025 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 昆药集团 |
| Ticker | 600422 |
| Exchange | SSE |
| Sector | 证监会行业分类 |
| Industry | C27医药制造业 |
| Market Segment | Main Board |
| Fiscal Year | 2025 |
| Currency | CNY |
| Market Cap | 8.9B |
| Market Cap (USD) | $1.2B |
| Revenue | 6.6B |
| Net Income | 419.0M |
| P/E Ratio | - |
| EPS | 0.46 |
| Net Margin | 6.4% |
| ROE | 6.0% |
| Dividend Yield | - |
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections and others. The company's brands such as Luotai, Tianxuanqing, Artemedine, Artem and Arco. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.